Search

Search results

486 results found

Shifting Focus

Shifting research focus is rarely neat, and almost never easy. After years of building expertise in one area, it can feel unsettling to acknowledge that priorities have shifted—funders, institutions, and entire fields evolve, and scholars must evolve with them. The process can bring with it a...

What Makes Cefpodoxime an Empiric Drug of Choice to Treat Lower Respiratory Tract Infections, including Acute Exacerbation of Chronic Obstructive Pulmonary Disease, in the Real-world Setting in India?

Talwar, Deepak, Agam Vora, Chandrakant Tarke, Asmita Mehta, Naveed Nazir Shah, and Sonia Dalal. 2025. “What Makes Cefpodoxime an Empiric Drug of Choice to Treat Lower Respiratory Tract Infections, Including Acute Exacerbation of Chronic Obstructive Pulmonary Disease, in the Real-World Setting in India?”. The Journal of the Association of Physicians of India 73 (10): e55-e59.

Review of Safety and Efficacy of Polmacoxib: A Novel Dual Inhibitor of Cyclo-oxygenase 2 and Carbonic Anhydrase in Osteoarthritis and Acute Painful Conditions.

Gunjal, Vijaya Sandeep, Roshan Rambhau Pawar, and Akhilesh Dayanand Sharma. 2025. “Review of Safety and Efficacy of Polmacoxib: A Novel Dual Inhibitor of Cyclo-Oxygenase 2 and Carbonic Anhydrase in Osteoarthritis and Acute Painful Conditions.”. The Journal of the Association of Physicians of India 73 (10): 88-92.

Analysis of Anticancer Drugs Used to Treat Brain Cancer Using the Cheapest and Costliest Drugs in India: A Cost-comparison Health Economics Study.

Simon, Paul, Abhishek Krishna, Namitha K Baby, Prerana Baruah, Sahana Srinivasan, and Jeco J Kuttykandathil. 2025. “Analysis of Anticancer Drugs Used to Treat Brain Cancer Using the Cheapest and Costliest Drugs in India: A Cost-Comparison Health Economics Study.”. The Journal of the Association of Physicians of India 73 (10): e18-e23.